Companies · Other Technology

Clinical Outcomes Management Systems Llc

CLEVELAND · Other Technology

Diligence memoA one-page analyst read on Clinical Outcomes Management Systems Llc — recommendation, valuation, rhythm, risks.
$8.6M
Total raised · real
4
Rounds
0.6×
Latest step-up
Top 31%
Sector rank · raised
Series A
Latest stage · inferred · Mon Nov 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Clinical Outcomes Management Systems Llc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.14× the median modeled value of Series A Other Technology companies in 2013–2015 (789 peers) — value vs value, same stage and era.
Dormant
  • Last raise 10.7 yr ago; this sector typically re-raises about every 13 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Clinical Outcomes Management Systems Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
17.6 yr record
Peak capital year was 2008 with $7.8M across 3 filings.
Market position
ahead of 70% of Other Technology peers
Capital scale is ahead of 70% of Other Technology peers; modeled value is above 37% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2008: $7.8M across 3 filings.
  • Largest single filing was $4.9M on 2008-12-01.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Technology

Clinical Outcomes Management Systems Llc is one of 21302 Other Technology companies tracked from CLEVELAND. By capital raised it ranks in the upper tier (ahead of 70% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2008-12-01 Raised $4.9M (real) Modeled valuation $136M (est)$4.9M$136MSeries A2008Seed · 2008-12-01 Raised $1.7M (real) Modeled valuation $58M (est)$1.7M$58MSeed2008Seed · 2008-12-01 Raised $1.2M (real) Modeled valuation $41M (est)$1.2M$41MSeed2008Series A · 2015-11-02 Raised $750K (real) Modeled valuation $21M (est)$750K$21MSeries A2015+$1.7M+$1.2M+$750KCumulative $8.6M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$4.9M · 2008
Bridge · Series A-stage$1.7M · 2008smaller follow-on
Bridge · Series A-stage$1.2M · 2008smaller follow-on
Series A extension$750K · 2015

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$20.8M
Base estimate est.
$1.0M
Conservative case
$113.1M
Upside case
$3.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.

Series A · modeled $135.9M · 2008-12-012008Seed · modeled $57.9M · 2008-12-01Seed · modeled $40.9M · 2008-12-01Series A · modeled $20.8M · 2015-11-022015
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
54%
Survival probability
29% low · 74% high
1.50×/yr
Annual markup
1.89×/yr upside case
6.0 yr
Elapsed time used
10.7 yr actual, capped for stale marks
technology
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
28 mo
Avg between rounds
$1.2M/yr
Capital velocity
17.6 yr
On record since
2008
First round
4
Rounds on file
How it compares to the market

Benchmarked against 21302 companies in Other Technology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.7× above median
This company$8.6M
Sector median$3.2M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.1× of median
This company$750K
Sector median$5.8M
Modeled value — vs sector median (estimate, all stages) 0.6× of median
This company$20.8M
Sector median$37.3M

Raised more than 70% of sector peers (real $). Modeled value above 37% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #739 of 789.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Uni-Pixel · Series A Raised $19.4M · modeled $416.1M (est)FoundationDB, Inc. · Series A Raised $15.0M · modeled $416.1M (est)Liaison Technologies, Inc. · Series A Raised $25.9M · modeled $416.1M (est)iDevices, LLC · Series A Raised $25.7M · modeled $416.1M (est)Zafin Global Holdings Corp. · Series A Raised $15.0M · modeled $416.1M (est)Lavu Inc · Series A Raised $15.0M · modeled $416.1M (est)Exostar Corp · Series A Raised $15.0M · modeled $416.1M (est)ikaSystems Corp · Series A Raised $27.5M · modeled $416.1M (est)Olapic, Inc. · Series A Raised $21.3M · modeled $416.1M (est)Rage Frameworks, Inc. · Series A Raised $15.0M · modeled $416.1M (est)Vormetric Inc · Series A Raised $15.0M · modeled $416.1M (est)BlueData Software, Inc. · Series A Raised $19.0M · modeled $416.1M (est)Clinical Outcomes Management Systems Llc (this company) Raised $8.6M · modeled $20.8M (est)Clinical Outcomes Management Systems Llc
CompanyStageRaised · realValue · estvs peer med.
Uni-PixelSeries A$19.4M$416.1M2.73×
FoundationDB, Inc.Series A$15.0M$416.1M2.73×
Liaison Technologies, Inc.Series A$25.9M$416.1M2.73×
iDevices, LLCSeries A$25.7M$416.1M2.73×
Zafin Global Holdings Corp.Series A$15.0M$416.1M2.73×
Lavu IncSeries A$15.0M$416.1M2.73×
Exostar CorpSeries A$15.0M$416.1M2.73×
ikaSystems CorpSeries A$27.5M$416.1M2.73×
Olapic, Inc.Series A$21.3M$416.1M2.73×
Rage Frameworks, Inc.Series A$15.0M$416.1M2.73×
Vormetric IncSeries A$15.0M$416.1M2.73×
BlueData Software, Inc.Series A$19.0M$416.1M2.73×
Clinical Outcomes Management Systems Llc this companySeries A$8.6M$20.8M0.14×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$4.9M2008-12-01$22.3M$135.9M90%
Seed$1.7M2008-12-01$8.5M$57.9M90%
Seed$1.2M2008-12-01$6.0M$40.9M90%
Series A$750K2015-11-02$3.4M$20.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$4.9M2008-12-01
    • First recorded raise — entered as Series A.
  2. Seed$1.7M2008-12-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.9× smaller than the prior — bridge or down round.
  3. Seed$1.2M2008-12-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
  4. Series A$750K2015-11-02
    • Raised again after 83 mo — slower than the ~13 mo sector norm.
    • Round 1.6× smaller than the prior — bridge or down round.
Intelligence
2018 ~Q1
Modeled next raise · ~28mo cadence
$750K
Modeled next size est.range $750K$1.2M
0.6×
Last step-up
$1.2M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Paul Carleton1 other2015-11
Christopher James McKenna2008-12
Donna Zapis Thomas2008-12
Edward J. Tromczynksi2008-12
Frederick Croft2015-11
James Joseph Riemenschneider2008-12
Jesse A. Lane2015-11
John F Zak2008-12
Len A. Pagon2015-11
Len F. Pagon2008-12
Mark A. Delaar2015-11
Michael Paull2015-11
Paul Hunter Carleton2008-12
Thomas Albert Riemenschneider2008-12
William A. Stuart2015-11
Registry & provenance

Clinical Outcomes Management Systems Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1456002
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Content Raven, Inc.Other TechnologySeries A$8.4M$20.6Msame sector · same stage
Vertical Acuity, IncOther TechnologySeries A$8.3M$20.8Msame sector · same stage
Washington Abstract, Inc.Other TechnologySeries A$8.8M$20.7Msame sector · same stage
ForMotiv Inc.Other TechnologySeries A$8.2M$20.4Msame sector · same stage
Alldigital Holdings, Inc.Other TechnologySeries A$9.0M$20.8Msame sector · same stage
Citizens Reserve, Inc.Other TechnologySeries A$9.1M$20.8Msame sector · same stage
PrefLogic Inc.Other TechnologySeries A$7.9M$20.8Msame sector · same stage
Opendate, Inc.Other TechnologySeries A$9.6M$20.9Msame sector · same stage
Frequently asked
How much funding has Clinical Outcomes Management Systems Llc raised?
Clinical Outcomes Management Systems Llc has raised approximately $8.6M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Clinical Outcomes Management Systems Llc's estimated valuation?
Provath's modeled valuation for Clinical Outcomes Management Systems Llc is approximately $20.8M (modeled range $1.0M–$113.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Clinical Outcomes Management Systems Llc at?
Clinical Outcomes Management Systems Llc's latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Nov 02.
What does Clinical Outcomes Management Systems Llc do and where is it based?
Clinical Outcomes Management Systems Llc operates in the Other Technology sector, based in CLEVELAND.
Explore related

See where Clinical Outcomes Management Systems Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Clinical Outcomes Management Systems Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.